ASSET PURCHASE AGREEMENT among: INOTIV – BOULDER HTL, LLC, as Purchaser, HISTOTOX LABS, INC, as Seller, JON BISHOP, as the sole stockholder of Seller And INOTIV, INC., as Parent Dated April 13, 2021Asset Purchase Agreement • April 19th, 2021 • Inotiv, Inc. • Services-commercial physical & biological research • Delaware
THIS ASSET PURCHASE AGREEMENT (this "Agreement") is being entered into effective as of April 13, 2021 (the "Effective Date"), by and among HistoTox Labs, Inc., a Colorado corporation ("Seller"), Jon Bishop, an individual residing in Boulder, Colorado (the "Stockholder"; and collectively with Seller, the "Selling Parties" and each individually a "Selling Party"), Inotiv – Boulder HTL, LLC, an Indiana limited liability company ("Purchaser"), and Inotiv, Inc., an Indiana corporation ("Parent").
AGREEMENT AND PLAN OF MERGER among: INOTIV BOULDER, LLC, as Merger Sub LLC, ROCK MERGECO, INC., as Merger Sub INOTIV, INC., as Parent BOLDER BIOPATH INC., as Company, Alison Bendele, and Phillip Bendele Dated April 15, 2021Merger Agreement • April 19th, 2021 • Inotiv, Inc. • Services-commercial physical & biological research • Indiana
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is being entered into effective as of April 15, 2021 (the "Effective Date"), by and among Inotiv, Inc., an Indiana corporation ("Parent"), Rock Mergeco, Inc., a Colorado corporation ("Merger Sub"), Inotiv Boulder, LLC, an Indiana limited liability company and a wholly-owned subsidiary of Parent ("Merger Sub LLC" and together with Merger Sub, "Merger Subs"), Bolder BioPATH Inc., a Colorado corporation ("Company"), and Alison Bendele and Phillip Bendele, collectively, the holders of all of the outstanding common shares of the Company (collectively, the "Stockholders" and each individually a "Stockholder" and together with the Company, the "Company Parties").
